Delivery Order SPE2DB22D3010-SPE2DB23FP3AM
Award Date
9/29/23
Potential Completion Date
10/2/23
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,199.30 firm fixed-price delivery order is for the supply of 4 mg ondansetron hydrochloride tablets. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,982.89 firm fixed-price delivery order is for the procurement of 4,566,409,405 units of the drug Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,480.59 firm fixed-price delivery order is for the supply of 4,561,682,676 units of the generic medication Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of August 3, 2023. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,455.02 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. The contract has a completion date of November 8, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $34,141.98, is for the delivery of 4,564,435,878 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,368.76 firm fixed-price delivery order contract is for the supply of 4,566,436,212 units of the drug Ondansetron HCl 4 mg tablet, with a period of performance through November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,406.11 Firm Fixed Price Delivery Order is for 4,562,236,655 units of Ondansetron HCL 4 MG Tablets, with an ultimate completion date of September 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,863.27, is a delivery order for 4,566,915,756 units of the drug Ondansetron ODT 4 mg tablet in 30-count packages. The contract has a firm fixed price and an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,564,514,283 units of Ondansetron ODT 4 mg tablets. The $6,434.62 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 6, 2024, with a completion date of May 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,872.79 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 6, 2023 and was awarded on December 5, 2023 with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...